<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04865614</url>
  </required_header>
  <id_info>
    <org_study_id>COMPETENT</org_study_id>
    <nct_id>NCT04865614</nct_id>
  </id_info>
  <brief_title>Comparison Between Inhalation and Intravenous Induction of Anaesthesia During Interventional Mitral Valve Repair</brief_title>
  <acronym>COMPETENT</acronym>
  <official_title>Comparison Between Inhalation and Intravenous Induction of Anaesthesia During Interventional Mitral Valve Repair</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Heidelberg University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Hospital, Essen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Heidelberg University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The induction of anaesthesia is one of the most critical situations for high-risk-patients&#xD;
      undergoing interventions surgery. For several reasons, it is crucial to maintain adequate&#xD;
      blood pressure and cardiac output during this phase.&#xD;
&#xD;
      This retrospective cohort study aims to find out if the choice of the induction agent has a&#xD;
      major impact on blood pressure and the use of catecholamines during the induction and the&#xD;
      interventional procedure in patients undergoing interventional mitral valve repair.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 1, 2019</start_date>
  <completion_date type="Actual">December 1, 2020</completion_date>
  <primary_completion_date type="Actual">December 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Post-induction hypotension</measure>
    <time_frame>First 20 minutes after induction of anaesthesia</time_frame>
    <description>Hypotension in the first 20 minutes after induction of anesthesia</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Use of catecholamines after induction during the first 20 minutes after inductionafter induction</measure>
    <time_frame>First 20 minutes after induction</time_frame>
    <description>Use of catecholamines during the first 20 minutes after induction of anaesthesia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Use of catecholamines</measure>
    <time_frame>Length of procedure (Approximately 60 to 90 minutes in average)</time_frame>
    <description>Use of catecholamines during the procedure</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">57</enrollment>
  <condition>Blood Pressure</condition>
  <condition>Hypotension Drug-Induced</condition>
  <arm_group>
    <arm_group_label>Etomidate group</arm_group_label>
    <description>Patients who received etomidate for induction of anaesthesia during interventional mitral valve repair (Mitraclip)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sevoflurane group</arm_group_label>
    <description>Patients who received sevoflurane for induction of anaesthesia during interventional mitral valve repair (Mitraclip)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Etomidate</intervention_name>
    <description>Use of etomidate</description>
    <arm_group_label>Etomidate group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sevoflurane</intervention_name>
    <description>Use of sevoflurane</description>
    <arm_group_label>Sevoflurane group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing interventional mitral valve repair&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients undergoing elective interventional mitral valve repair&#xD;
&#xD;
          -  Sevoflurane or etomidate have been used for induction of anesthesia&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Adrian E Stephan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Heidelberg University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Anästhesiologische Klinik (Universitätsklinikum Heidelberg)</name>
      <address>
        <city>Heidelberg</city>
        <state>Baden-Würtemberg</state>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>April 26, 2021</study_first_submitted>
  <study_first_submitted_qc>April 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 29, 2021</study_first_posted>
  <last_update_submitted>October 25, 2021</last_update_submitted>
  <last_update_submitted_qc>October 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Heidelberg University</investigator_affiliation>
    <investigator_full_name>Dr. Adrian Stephan</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypotension</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sevoflurane</mesh_term>
    <mesh_term>Etomidate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

